{"filing":{"accession_number":"0001213900-26-099416","cik":"0002075320","ticker":"PLYX","company_name":"Polaryx Therapeutics, Inc.","form":"8-K","filing_date":"2026-09-11","report_date":"2026-09-10","primary_document":"ea0305352-8k_polaryx.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/ea0305352-8k_polaryx.htm"},"events":[{"id":33054,"run_id":30381,"accession_number":"0001213900-26-099416","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a classic Item 5.07 disclosure reporting the results of Polaryx's Annual Meeting of Stockholders held on September 10, 2026. The filing presents voting results for two proposals: (1) election of Class I Directors (Alex Yang and Mitchel Berger, each receiving 30,072,137 votes for), and (2) ratification of Grant Thorton LLP as independent auditor (30,510,106 votes in favor). This is a routine but material shareholder governance event that affects investor understanding of board composition and audit oversight.","company_name":"Polaryx Therapeutics, Inc.","ticker":"PLYX","filing_date":"2026-09-11","form":"8-K","submitted_at":null,"items":[{"id":36386,"accession_number":"0001213900-26-099416","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Polaryx's Annual Meeting of Stockholders held on September 10, 2026. The filing presents voting results for two proposals: (1) election of Class I Directors (Alex Yang and Mitchel Berger, each receiving 30,072,137 votes for), and (2) ratification of Grant Thorton LLP as independent auditor (30,510,106 votes in favor). This is a routine but material shareholder governance event that affects investor understanding of board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T10:03:15.146872+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":36386,"accession_number":"0001213900-26-099416","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Polaryx's Annual Meeting of Stockholders held on September 10, 2026. The filing presents voting results for two proposals: (1) election of Class I Directors (Alex Yang and Mitchel Berger, each receiving 30,072,137 votes for), and (2) ratification of Grant Thorton LLP as independent auditor (30,510,106 votes in favor). This is a routine but material shareholder governance event that affects investor understanding of board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-14T10:03:15.146872+00:00","company_name":"Polaryx Therapeutics, Inc.","ticker":"PLYX","filing_date":"2026-09-11"}]}